Drug intelligence / Profile preview

telomerase gene therapy (Telocyte)

Development stage
Preclinical
Lead developer
Telocyte
Modality
Gene Therapies
Administration
Intrathecal
01

Overview

Telocyte's telomerase gene therapy is an investigational regenerative treatment for Alzheimer's disease, currently in the preclinical stage. Developed by Telocyte, the therapy utilizes a viral vector (typically AAV) to deliver the human telomerase reverse transcriptase (hTERT) gene directly to neurons and glial cells within the central nervous system. The primary objective is to relengthen critically short telomeres, thereby reversing cellular senescence—a state of functional decline and pro-inflammatory signaling that contributes to neurodegeneration. By resetting the cellular aging clock, the therapy aims to restore cellular health, improve metabolic function, and halt or reverse the progression of Alzheimer's disease pathology.

Other names
Telomerase Gene TherapyhTERT gene therapyTelocyte Alzheimer's therapyTelocyte-Telomerase (TERT)-telomeres-gene therapy-Alzheimer's disease
02

Targets

TERT (Telomerase)

Beyond the preview

Go deeper on telomerase gene therapy (Telocyte).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on telomerase gene therapy (Telocyte).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call